Ixazomib and lenalidomide maintenance therapy in multiple myeloma

Ricardo D. Parrondo; Victoria Alegria; Vivek Roy; Taimur Sher; Asher A. Chanan-Khan; Sikander Ailawadhi

doi:10.1007/s00277-020-04340-8

Ixazomib and lenalidomide maintenance therapy in multiple myeloma

Ricardo D. Parrondo, Victoria Alegria, Vivek Roy, Taimur Sher, Asher A. Chanan-Khan, Sikander Ailawadhi

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	851-853
Number of pages	3
Journal	Annals of hematology
Volume	100
Issue number	3
DOIs	https://doi.org/10.1007/s00277-020-04340-8
State	Published - Mar 2021

ASJC Scopus subject areas

Hematology

Access to Document

10.1007/s00277-020-04340-8

Cite this

@article{f32abd9d4c5f4d30a6858bed2580c4d9,

title = "Ixazomib and lenalidomide maintenance therapy in multiple myeloma",

author = "Parrondo, {Ricardo D.} and Victoria Alegria and Vivek Roy and Taimur Sher and Chanan-Khan, {Asher A.} and Sikander Ailawadhi",

note = "Funding Information: S.A. received honoraria from Celgene and Takeda and research funding from Amgen, Janssen, Pharmacyclics, Cellectar, Bristol-Myers Squibb, Phosphatin and Medimmune. ",

year = "2021",

month = mar,

doi = "10.1007/s00277-020-04340-8",

language = "English (US)",

volume = "100",

pages = "851--853",

journal = "Annals of hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Ixazomib and lenalidomide maintenance therapy in multiple myeloma

AU - Parrondo, Ricardo D.

AU - Alegria, Victoria

AU - Roy, Vivek

AU - Sher, Taimur

AU - Chanan-Khan, Asher A.

AU - Ailawadhi, Sikander

N1 - Funding Information: S.A. received honoraria from Celgene and Takeda and research funding from Amgen, Janssen, Pharmacyclics, Cellectar, Bristol-Myers Squibb, Phosphatin and Medimmune.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85095439991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095439991&partnerID=8YFLogxK

U2 - 10.1007/s00277-020-04340-8

DO - 10.1007/s00277-020-04340-8

M3 - Letter

C2 - 33161454

AN - SCOPUS:85095439991

SN - 0939-5555

VL - 100

SP - 851

EP - 853

JO - Annals of hematology

JF - Annals of hematology

IS - 3

ER -

Ixazomib and lenalidomide maintenance therapy in multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this